Group 6 Copy 51
-2
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Examining firearm recoil on neurometabolic changes associated with traumatic brain injury

    Sport concussion is currently a widely researched topic. Shooting sports do not impose a direct blow to the...

    Blinded by the light: reducing shearwater deaths along a coastal highway in O'ahu, Hawai'i

    Wedge-tailed Shearwater chicks are attracted to lights and grounded due to collisions with utility wires / posts...

    Help me sequence wild populations of a medicinal plant (Pilocarpus)

    I'm studying an important medicinal plant in the citrus family, commonly known as Jaborandi(Pilocarpus). Compounds...

    Backer Badge Funded

    A biology project funded by 47 people